As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate ...

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that ...

This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...

In the first part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, explains how steep pharmaceutical import tariffs might affect costs at different points in ...

Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan ...

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

The CDMO’s new services at its Hopewell, NJ facility delivers scalable, phase-appropriate production, in-house quality ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

The GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate cap.